The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 31, 2021
Filed:
Feb. 23, 2017
Applicant:
Probiogen Ag, Berlin, DE;
Inventors:
Ingo Jordan, Berlin, DE;
Volker Sandig, Berlin, DE;
Assignee:
Probiogen AB, Berlin, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/12 (2006.01); C12N 15/86 (2006.01); C12N 7/00 (2006.01); C12N 15/00 (2006.01); A61K 39/285 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/285 (2013.01); C07K 14/005 (2013.01); A61K 2039/525 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24122 (2013.01); C12N 2710/24134 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24164 (2013.01);
Abstract
The present invention relates to a novel Modified Vaccinia Ankara (MVA) related virus. The present invention also relates to a method for culturing said MVA related virus and to a method for producing said MVA related virus. Further, the present invention relates to a pharmaceutical composition comprising said MVA related virus and one or more pharmaceutical acceptable excipient(s), diluent(s), and/or carrier(s). Furthermore, the present invention relates to a vaccine comprising said MVA related virus. In addition, the present invention relates to said MVA related virus for use in medicine.